Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Prins

Showing results (581-590 of 722) with videos related to

Pageof 73
Sort By:
Scientific Reports|February 28, 2019
Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistryArarat Chakhoyan, Jingwen Yao, Kevin Leu, et al.
The Netherlands Journal of Medicine|December 9, 2017
Non-targeted HIV screening in emergency departments in the NetherlandsG P M Luiken, I K Joore, A Taselaar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Detection of immune responses after immunotherapy in glioblastoma using PET and MRIJoseph P Antonios, Horacio Soto, Richard G Everson, et al.
Nature Communications|November 27, 2021
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastomaAlexander H Lee, Lu Sun, Aaron Y Mochizuki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 2, 2007
Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN)Katalin Pogány, Irene G M van Valkengoed, Irene G Vanvalkengoed, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 13, 2008
[An early switch from intravenous to oral antibiotics is equally effective as the standard intravenous therapy in severe community acquired pneumonia]J J Oosterheert, M J M Bonten, M M E Schneider, et al.
AIDS (London, England)|August 24, 2011
Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 controlDaniëlle van Manen, Luuk Gras, Brigitte D Boeser-Nunnink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2024
Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth AnalysisBerend J van Welzen, Steven F L Van Lelyveld, Gerjanne Ter Beest, et al.
AIDS Research and Human Retroviruses|February 25, 2016
The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting SubtypeMarion Cornelissen, Zelda Euler, Tom L G M van den Kerkhof, et al.
Antimicrobial Resistance and Infection Control|October 31, 2021
Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort studySophie Coenen, Jara R de la Court, David T P Buis, et al.
Pageof 73

Showing results (581-590 of 722) with videos related to

Sort By:
Pageof 73
Scientific Reports|February 28, 2019
Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistryArarat Chakhoyan, Jingwen Yao, Kevin Leu, et al.
The Netherlands Journal of Medicine|December 9, 2017
Non-targeted HIV screening in emergency departments in the NetherlandsG P M Luiken, I K Joore, A Taselaar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2017
Detection of immune responses after immunotherapy in glioblastoma using PET and MRIJoseph P Antonios, Horacio Soto, Richard G Everson, et al.
Nature Communications|November 27, 2021
Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastomaAlexander H Lee, Lu Sun, Aaron Y Mochizuki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 2, 2007
Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN)Katalin Pogány, Irene G M van Valkengoed, Irene G Vanvalkengoed, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 13, 2008
[An early switch from intravenous to oral antibiotics is equally effective as the standard intravenous therapy in severe community acquired pneumonia]J J Oosterheert, M J M Bonten, M M E Schneider, et al.
AIDS (London, England)|August 24, 2011
Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 controlDaniëlle van Manen, Luuk Gras, Brigitte D Boeser-Nunnink, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2024
Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth AnalysisBerend J van Welzen, Steven F L Van Lelyveld, Gerjanne Ter Beest, et al.
AIDS Research and Human Retroviruses|February 25, 2016
The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting SubtypeMarion Cornelissen, Zelda Euler, Tom L G M van den Kerkhof, et al.
Antimicrobial Resistance and Infection Control|October 31, 2021
Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort studySophie Coenen, Jara R de la Court, David T P Buis, et al.
Pageof 73